Literature DB >> 27423605

White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease.

Yaroslau Compta1, Mariateresa Buongiorno1, Núria Bargalló2, Francesc Valldeoriola1, Esteban Muñoz1, Eduardo Tolosa1, José Ríos3, Ana Cámara1, Manel Fernández1, Maria J Martí4.   

Abstract

Entities:  

Keywords:  Amyloid-β; Cerebrospinal fluid; Dementia; Parkinson's disease; White matter hyperintensities

Mesh：

Substances：

Year:  2016        PMID： 27423605     DOI： 10.1016/j.jns.2016.06.009

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  9 in total

Review 1.  Changes of cerebrospinal fluid Aβ42, t-tau, and p-tau in Parkinson's disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis.

Authors:  Xiaohui Hu; Yan Yang; Daokai Gong
Journal:  Neurol Sci       Date:  2017-08-14       Impact factor: 3.307

Review 2.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

3.  White Matter Lesions in Mild Cognitive Impairment and Idiopathic Parkinson's Disease: Multimodal Advanced MRI and Cognitive Associations.

Authors:  Swati Rane; Julia Owen; Daniel S Hippe; Brenna Cholerton; Cyrus P Zabetian; Tom Montine; Thomas J Grabowski
Journal:  J Neuroimaging       Date:  2020-09-16       Impact factor: 2.486

4.  Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts.

Authors:  Benjamin K Dawson; Seyed-Mohammad Fereshtehnejad; Julius B M Anang; Takashi Nomura; Silvia Rios-Romenets; Kenji Nakashima; Jean-François Gagnon; Ronald B Postuma
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

Review 5.  Amyloid-β and Parkinson's disease.

Authors:  Ee Wei Lim; Dag Aarsland; Dominic Ffytche; Raquel Natalia Taddei; Daniel J van Wamelen; Yi-Min Wan; Eng King Tan; Kallol Ray Chaudhuri
Journal:  J Neurol       Date:  2018-10-30       Impact factor: 4.849

6.  White Matter Hyperintensities in Older Adults and Motoric Cognitive Risk Syndrome.

Authors:  Joanna L Mergeche; Joe Verghese; Gilles Allali; Cuiling Wang; Olivier Beauchet; V G Pradeep Kumar; P S Mathuranath; Jennifer Yuan; Helena M Blumen
Journal:  J Neuroimaging Psychiatry Neurol       Date:  2016-11-03

7.  Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Authors:  Kurt A Jellinger; Amos D Korczyn
Journal:  BMC Med       Date:  2018-03-06       Impact factor: 8.775

8.  Beta amyloid deposition and cognitive decline in Parkinson's disease: a study of the PPMI cohort.

Authors:  Alexander S Mihaescu; Mikaeel Valli; Carme Uribe; Maria Diez-Cirarda; Mario Masellis; Ariel Graff-Guerrero; Antonio P Strafella
Journal:  Mol Brain       Date:  2022-09-13       Impact factor: 4.399

9.  White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.

Authors:  Mahsa Dadar; Yashar Zeighami; Yvonne Yau; Seyed-Mohammad Fereshtehnejad; Josefina Maranzano; Ronald B Postuma; Alain Dagher; D Louis Collins
Journal:  Neuroimage Clin       Date:  2018-09-27       Impact factor: 4.881
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.